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1. Introduction 
Artificial regulation of gene expression is quite important for basic study to analyze 
unknown biological functions of target genes. Comparison of phenotypes with and without 
knockdown of expression level of the target genes may be helpful to reveal unknown 
biological functions of the target genes. Artificial regulation of gene expression is also 
important for therapeutic applications to reduce expression level of mutated target genes. 
Knockdown of expression level of the mutated target genes may be useful to avoid 
undesirable effects produced by the mutated target genes. Antisense and antigene 
technologies are powerful tools to artificially regulate target gene expression. In antisense 
technology, a single-stranded oligonucleotide added from outside may bind with target 
mRNA to form oligonucleotide-RNA duplex[1,2]. The formed duplex may inhibit ribosome-
mediated translation of target mRNA due to its steric hindrance, or RNaseH may cleave 
target mRNA in the formed duplex, which may result in reduction of expression level of 
target mRNA in both cases[1,2]. In antigene technology, a single-stranded homopyrimidine 
triplex-forming oligonucleotide (TFO) added from outside may bind with homopurine-
homopyrimidine stretch in target duplex DNA by Hoogsteen hydrogen bonding to form 
pyrimidine motif triplex, where TA:T and C+G:C base triplets are formed[3,4]. The 
formed triplex inhibits RNA polymerase and transcription factors-mediated transcription of 
target gene due to its steric hindrance, which may result in downregulation of expression 
level of target gene[3,4]. 
Serious difficulties, such as poor binding ability of added oligonucleotides with target 
mRNA or target duplex DNA[5-7], and low stability of added oligonucleotides against 
nuclease degradation[8], may limit practical applications of the antisense and antigene 
technologies in vivo. Many kinds of chemically modified oligonucleotides have been 
developed to overcome these serious difficulties[9]. In this context, we have developed a 
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novel class of chemical modification of nucleic acids, 2’-O,4’-C-aminomethylene bridged 
nucleic acid (2’,4’-BNANC), in which 2’-O and 4’-C of the sugar moiety are bridged with the 
aminomethylene chain (Figure 1a)[10,11]. 2’,4’-BNANC-modified oligonucleotides showed 
higher binding affinity with target mRNA[11], stronger binding ability with target duplex 
DNA to form triplex[10-13], and higher stability against nuclease degradation than the 
corresponding unmodified oligonucleotides[11-13]. These excellent properties of 2’,4’-
BNANC-modification of oligonucleotides may be favorable for their practical applications to 
the antisense and antigene technologies. 
 
(a) 
(b) 
Forward strand
F12       5’-d(GCGTTTTTTGCT)-3’ 
F12-1     5’-d(GCGTTTTTTGCT)-3’ 
F12-31    5’-d(GCGTTTTTTGCT)-3’ 
F12-32    5’-d(GCGTTTTTTGCT)-3’ 
F12-6     5’-d(GCGTTTTTTGCT)-3’ 
Complementary strand 
R12R      3’-r(CGCAAAAAACGA)-5’ 
R12X      3’-r(CGCAAXAAACGA)-5’(X=A, U, G, C) 
R12D      3’-d(CGCAAAAAACGA)-3’ 
T: T with 2’-O,4’-C-aminomethylene bridge 
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Figure 1. a) Structural formulas for phosphodiester (PO) and 2’-O,4’-C-aminomethylene bridged 
nucleic acid (2’,4’-BNANC)-modified backbones. (b) Oligonucleotide sequences for the unmodified (F12) 
or 2′,4′-BNANC-modified (F12-1, F12-31, F12-32, F12-6) oligonucleotide, the complementary RNA (R12R), 
the complementary single-mismatched RNA (R12X) and the complementary DNA (R12D) (c) 
Oligonucleotide sequences for the target duplex (Pur23APyr23T), the specific TFOs (Pyr15TM, 
Pyr15NC7-1, Pyr15NC7-2, Pyr15NC5-1, and Pyr15NC5-2), and the nonspecific oligonucleotide 
(Pyr15NS2M). (d) Oligonucleotide sequences for the 2’,4’-BNANC-modified antisense oligonucleotides to 
target a certain region of PCSK9 gene.   
(c) 
(d)
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In this chapter, we describe the excellent properties of 2’,4’-BNANC-modified 
oligonucleotides for higher ability to form duplex and triplex and for higher nuclease 
resistance[11-13]. We also show the biological application of 2’,4’-BNANC-modified 
oligonucleotides to reduce expression level of target mRNA in mammalian cells[14]. PCSK9 
is a serine protease involved in the degradation of LDL receptor [15-17]. Suppression of 
PCSK9 by reducing expression level of PCSK9 mRNA may cause an increase in the amount 
of the LDL receptor, resulting in the reduction of serum LDL cholesterol level. Thus, the 
PCSK9 mRNA has the potential to be an antisense target for the treatment of 
hypercholesterolemia [15-17]. We present the excellent antisense effect of 2’,4’-BNANC 
modified antisense oligonucleotides to reduce the expression level of the PCSK9 mRNA. 
2. Methods to prepare and characterize oligonucleotides 
2.1. Preparation of oligonucleotides 
We synthesized complementary oligonucleotides for duplex DNA and unmodified 
homopyrimidine TFO (Figure 1b, 1c) on a DNA synthesizer using the solid-phase 
cyanoethyl phosphoramidite method, and purified them with a reverse-phase high 
performance liquid chromatography on a Wakosil DNA or Waters X-Terra column. 2’,4’-
BNANC-modified oligonucleotides (Figure 1b, 1c, 1d) were synthesized and purified as 
described previously[10,11]. 5’-Biotinylated oligonucleotides were prepared from biotin 
phosphoramidite for kinetic analyses by Biacore described below. The concentration of 
all oligonucleotides was determined by UV absorbance. The reported extinction 
coefficient for poly (dT) [ε265 = 8700 cm-1 (mol of base/liter) -1][18] was used for 
unmodified and 2’,4’-BNANC-modified homopyrimidine TFO. Complementary strands 
for duplex DNA were annealed by heating at up to 90 ˚C, followed by a gradual cooling 
to room temperature. When the removal of unpaired single strands is necessary, the 
annealed sample was applied on a hydroxyapatite column (BioRad). The concentration 
of duplex DNA was determined by UV absorbance, considering DNA concentration ratio 
of 1 OD = 50 µg/ml. 
2.2. UV melting 
Heating of duplex results in monophasic strand dissociation based on the transition 
between the two states, duplex→2 single strands. Heating of triplex also leads to 
biphasic strand dissociation according to the transitions between the three states, 
triplex→ duplex + single strand→3 single strands. Base stacking interactions in the free 
strands are weaker than those in the bound strands, resulting in a hyperchromic increase 
in UV absorbance upon heating. UV melting monitors the process of duplex and triplex 
melting by the temperature dependent change in UV absorbance. First derivative plot of 
UV absorbance (dA/dT vs T) is calculated from the UV melting curve (A vs T). Peak 
temperatures in the first derivative plot correspond to the melting temperature, Tm, of 
the transition. 
 
Chemical Modification of Oligonucleotides: A Novel Approach Towards Gene Targeting 117 
UV melting experiments for duplex and triplex study were carried out on a DU-650 and 
DU-640 spectrophotometer (Beckman Inc.), respectively, equipped with a Peltier type cell 
holder. The cell path length was 1 cm. UV melting profiles for duplex study were measured 
in 10 mM sodium phosphate buffer at pH 7.2 containing 100 mM NaCl. UV melting profiles 
for triplex study were measured in 10 mM sodium cacodylate-cacodylic acid at pH 6.8 
containing 200 mM NaCl and 20 mM MgCl2. UV melting profiles were recorded at a scan 
rate of 0.5 °C/min with detection at 260 nm. The first derivative was calculated from the UV 
melting profile. The peak temperatures in the derivative curve were designated as the 
melting temperature, Tm. The duplex and triplex nucleic acid concentration used was 4 µM 
and 1 µM, respectively. 
2.3. CD spectroscopy 
CD spectroscopy is sensitive to interactions of nearby bases vertically stacked in strands. 
Stacking interactions depend on the conformational details of nucleic acid structure. CD 
spectra provide a certain basis for suggesting the overall conformation of strands in duplex 
and triplex. The appearance of an intense negative band at the short wavelength range (210-
220 nm) in CD spectra indicates the formation of triplex. 
CD spectra of the triplex at 20 oC were recorded in 10 mM sodium cacodylate-cacodylic acid 
at pH 6.8 containing 200 mM NaCl and 20 mM MgCl2 on a JASCO J-720 spectropolarimeter 
interfaced with a microcomputer. The cell path length was 1 cm. The triplex nucleic acid 
concentration used was 1 µM. 
2.4. Electrophoretic mobility shift assay (EMSA) 
The 32P-radiolabelled band of triplex migrates slower than that of duplex in native 
polyacrylamide gel electrophoresis. The formation of triplex results in appearance of a novel 
radiolabelled band shifted to a new position corresponding to triplex. The percentage of the 
formed triplex was calculated using the following equation: 
% triplex = [Striplex / (Striplex + Sduplex)] x 100 
where Striplex and Sduplex represent the radioactive signal for triplex and duplex bands, 
respectively. The dissociation constant, Kd, of triplex formation is determined from the 
concentration of the TFO, which causes half of target duplex to shift to triplex. 
EMSA experiments for the triplex formation were performed essentially as described 
previously by a 15% native polyacrylamide gel electrophoresis[12,13,19-27]. In a 9 µl of 
reaction mixture, 32P-labeled Pur23APyr23T duplex (~1 nM) (Figure 1c) was mixed with 
increasing concentrations of the specific TFO (Pyr15TM, Pyr15NC7-1, Pyr15NC7-2, 
Pyr15NC5-1, or Pyr15NC5-2) (Figure 1c) and the nonspecific oligonucleotide (Pyr15NS2M) 
(Figure 1c) in buffer [50 mM Tris-acetate (pH 7.0), 100 mM NaCl, and 10 mM MgCl2]. 
Pyr15NS2M was added to achieve equimolar concentrations of TFO in each lane as well as 
to minimize adhesion of the DNA (duplex and TFO) to plastic surfaces during incubation 
 
Mutagenesis 118 
and subsequent losses during processing. After 6 h incubation at 37 oC, 2 µl of 50 % glycerol 
solution containing bromophenol blue was added without changing the pH and salt 
concentrations of the reaction mixtures. Samples were then directly loaded onto a 15 % 
native polyacrylamide gel prepared in buffer [50 mM Tris-acetate (pH 7.0) and 10 mM 
MgCl2] and electrophoresis was performed at 8 V/cm for 16 h at 4 oC. 
2.5. Thermodynamic analyses by isothermal titration calorimetry (ITC) 
Isothermal titration calorimetry (ITC) relies upon the accurate measurement of heat changes 
caused by the interaction of molecules in solution and possesses the advantage of not 
requiring labeling or immobilization of the components[28]. ITC provides a great deal of 
thermodynamic information about the binding process from only a single experiment. This 
information includes the binding stoichiometry (n), the binding equilibrium constant (Ka), 
the enthalpy change (∆H) of binding, the entropy change (∆S) of binding and the Gibbs free 
energy change (∆G) of the binding process[28]. A syringe containing a solution of one 
element (in the case of triplex formation, duplex) is incrementally titrated into a cell 
containing a solution of the second element (in the case of triplex formation, TFO). As the 
duplex is added to the TFO, heat is released upon the triplex formation. The heat for each 
injection is measured by the ITC instrument and is plotted as a function of time over the 
injection series. The heat signal from each injection is determined by the area underneath the 
injection peak. The heat is plotted against the molar ratio of the duplex added to the TFO 
added to the duplex in the cell. The titration plot provides the thermodynamic information 
of the triplex formation. 
Isothermal titration experiments for the triplex formation were carried out on a VP ITC 
system (Microcal Inc., U.S.A.), essentially as described previously[12,13,19-22,25-27]. The 
TFO (Figure 1c) and Pur23APyr23T duplex (Figure 1c) solutions were prepared by 
extensive dialysis against 10 mM sodium cacodylate-cacodylic acid at pH 6.1 or pH 6.8 
containing 200 mM NaCl and 20 mM MgCl2. The Pur23APyr23T duplex solution in 10 mM 
sodium cacodylate-cacodylic acid at pH 6.1 or pH 6.8 containing 200 mM NaCl and 20 mM 
MgCl2 was injected 20-times in 5-µl increments and 10-min intervals into the TFO solution 
without changing the reaction conditions. The heat for each injection was subtracted by the 
heat of dilution of the injectant, which was measured by injecting the Pur23APyr23T 
duplex solution into the same buffer. Each corrected heat was divided by the moles of the 
Pur23APyr23T duplex solution injected, and analyzed with Microcal Origin software 
supplied by the manufacturer. 
2.6. Kinetic analyses by Biacore 
Biacore is one example of a class of optical biosensors which can be used to determine the 
kinetic binding parameters of molecular interactions, such as association rate constant 
(kassoc), dissociation rate constant (kdissoc) and binding constant (Ka)[29,30]. Biacore 
measurements are usually performed with one partner immobilized (in the case of triplex 
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formation, duplex) on a porous hydrogel to which the second component (in the case of 
triplex formation, TFO) then binds[29]. Changes in the mass loading at the sensor surface 
upon the triplex formation cause a shift in the resonance angle of light propagated through 
the wave-guiding structure immediately adjacent to the hydrogel. The time dependence of 
the change in resonance angle yields the kinetic information of the triplex formation. 
Kinetic experiments for the triplex formation were performed on a BIACORE J instrument 
(GE Healthcare, U.S.A.), in which a real-time biomolecular interaction was measured with a 
laser biosensor, essentially as described previously[12,13,19-25,27]. The layer of a SA sensor 
tip with immobilized streptavidin was equilibrated with 10 mM sodium cacodylate-
cacodylic acid at pH 6.8 containing 200 mM NaCl and 20 mM MgCl2 at a flow rate of 30 
µl/min. 40 µl of 50 mM NaOH containing 1 M NaCl was injected 3 times at a flow rate of 30 
µl/min to reduce electrostatic repulsion from the surface. After equilibrating with 10 mM 
sodium cacodylate-cacodylic acid at pH 6.8 containing 200 mM NaCl and 20 mM MgCl2, 
160 µl of 0.2 µM Bt(biotinylated)-Pyr23TPur23A duplex (Figure 1c) solution was added 
at a flow rate of 30 µl/min to bind with the streptavidin on the surface. After extensive 
washing and equilibrating the Bt-Pyr23TPur23A-immobilized surface with 10 mM 
sodium cacodylate-cacodylic acid at pH 6.8 containing 200 mM NaCl and 20 mM MgCl2, 
70 µl of the TFO (Figure 1c) solution in 10 mM sodium cacodylate-cacodylic acid at pH 6.8 
containing 200 mM NaCl and 20 mM MgCl2 was injected over the immobilized Bt-
Pyr23TPur23A duplex at a flow rate of 30 µl/min, and then the triplex formation was 
monitored for 2 min. This was followed by washing the sensor tip with 10 mM sodium 
cacodylate-cacodylic acid at pH 6.8 containing 200 mM NaCl and 20 mM MgCl2, and the 
dissociation of the preformed triplex was monitored for an additional 2.5 min. Finally, 40 
µl of 100 mM Tris-HCl (pH 8.0) for Pyr15TM (Figure 1c), or 40 µl of 10 mM NaOH (pH 12) 
for Pyr15NC7-1, Pyr15NC7-2, Pyr15NC5-1, and Pyr15NC5-2 (Figure 1c) was injected at a 
flow rate of 30 µl/min to completely break the Hoogsteen hydrogen bonding between the 
TFO and Pur23A, during which the Bt-Pyr23TPur23A duplex may be partially 
denatured. The Bt-Pyr23TPur23A duplex was regenerated by injecting 0.2 µM Pur23A. 
The resulting sensorgrams were analyzed with the BIA evaluation software supplied by 
the manufacturer to calculate the kinetic parameters. 
2.7. Stability of oligonucleotides in human serum against nuclease degradation 
Stability of oligonucleotides in human serum was examined by the following two 
procedures[12,13,26]. 
a. Analyses by native polyacrylamide gel electrophoresis 
Oligonucleotide (Figure 1c) was 5′-end labeled with 32P using [γ-32P] ATP and T4 
polynucleotide kinase by a standard procedure. 2 pmol 32P-labeled oligonucleotide was 
incubated at 37 oC in 200 µl of human serum from human male AB plasma (Sigma-Aldrich 
Co., USA). Aliquots of 5 µl were removed after 10, 20, 40, 60, and 120 min of incubation, and 
mixed with 5 µl of stop solution (80 % formamide, 50 mM EDTA) to terminate the reactions. 
The samples were loaded on 15 % native polyacrylamide gels prepared in buffer [50 mM 
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Tris-acetate (pH 7.0), 100 mM MgCl2], and electrophoresis was performed at 8 V/cm and  
4 oC. The gels were scanned and analyzed by BAS system. 
b. Analyses by anion-exchange HPLC 
1 nmol oligonucleotide (Figure 1c) was incubated at 37 oC in 20 µl of 50 % human serum 
from human male AB plasma (Sigma-Aldrich Co., USA). After incubation for 20, 60 and 120 
min, the samples were mixed with 13 µl of formamide to terminate the reactions, and stored 
at -80 oC until HPLC analyses. The samples were mixed with 400 µl of HPLC buffer [25 mM 
Tris-HCl (pH 7.0), 0.5 % CH3CN], and analyzed by anion-exchange HPLC on JASCO LC-
2000 Plus series with detection at 260 nm using a linear gradient of 0-0.5 M NH4Cl in HPLC 
buffer over 45 min to resolve the products. The HPLC column used was TSK-GEL DNA-
NPR (Tosoh, Japan). Under these conditions, peaks of all proteins from the human serum 
could be resolved from those of the intact and degraded TFO. Degradation data from the 
acquired chromatograms were processed using ChromNAV software as supplied by the 
manufacturer. 
2.8. In vitro assay of PCSK9 gene expression in mouse hepatocyte cell line, 
NMuLi 
Mouse hepatocyte cell line NMuLi (4.0 x 105 cells/ml) was cultivated in 6 well plates (2 
ml/well) and incubated for 24 hr at 37 oC under 5 % CO2. Antisense oligonucleotide to target 
a certain region of PCSK9 gene (Figure 1d), Lipofectamine 2000 (Invitrogen), and Opti-MEM 
(Invitrogen) were mixed. The final concentration of the antisense oligonucleotide in the 
mixture was adjusted to 1, 3, 10, 30 or 50 nM. After incubation of the mixture for 20 min at 
room temperature, the mixture was transfected into the cell line. Cell culture medium was 
exchanged into the new one at 4 hr after the transfection of the antisense oligonucleotide. 
Cells were collected at 20 hr after the exchange of the cell culture medium. The collected 
cells were homogenized by ISOGEN (Nippon Gene) to extract total RNA. Concentration of 
the extracted total RNA was measured by UV absorbance. Length of the extracted total RNA 
was analyzed by agarose gel electrophoresis. After adjusting the concentration of the total 
RNA to 4.0 µg/10 µl, we performed reverse transcription reaction using the total RNA to 
obtain 1st strand cDNA. Then, we carried out real-time PCR using the obtained cDNA to 
quantitate the expression levels of PCSK9 mRNA and control housekeeping GAPDH 
mRNA. We normalized the expression level of PCSK9 mRNA by that of control 
housekeeping GAPDH mRNA, because the antisense oligonucleotides did not affect the 
expression level of control housekeeping GAPDH mRNA. We examined the effect of the 
antisense oligonucleotides on the expression level of PCSK9 mRNA. 
3. Stabilization of duplex by 2’,4’-BNANC-modification 
Formation of stable duplexes with complementary single-stranded RNA (ssRNA) and 
single-stranded DNA (ssDNA) under physiological condition is essential for antisense and 
diagnostic applications. Thermal stability of duplexes formed between a 12-mer unmodified 
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(F12; Figure 1b) or 2′,4′-BNANC-modified (F12-1, F12-31, F12-32, F12-6; Figure 1b) 
oligonucleotide and each of its complementary 12-mer ssRNA (R12R; Figure 1b) and 12-mer 
ssDNA (R12D; Figure 1b) was examined at pH 7.2 by UV melting (Table 1). The Tm value of 
the duplex formed between the 12-mer oligonucleotide containing a single 2′,4′-BNANC-
modification (F12-1) and the complementary 12-mer ssRNA (R12R) increased by 6 °C 
compared to that of the duplex formed between the 12-mer unmodified oligonucleotide (F12) 
and R12R. Further incremental increase in Tm was observed upon an increase in the number of 
2′,4′-BNANC-modification (F12-31, F12-32, F12-6). The increase in Tm per 2′,4′-BNANC-
modification (∆Tm/modification) ranged from 5.3 to 6.3 °C. These results indicate that further 
2′,4′-BNANC-modification of oligonucleotide should produce very stable duplex with 
complementary ssRNA. On the other hand, a single 2′,4′-BNANC-modification increased the Tm 
value of the duplex formed with complementary 12-mer ssDNA (R12D) by only 1 °C 
(F12:R12D vs. F12-1:R12D), indicating that stabilization of duplex by 2′,4′-BNANC-modification 
is highly complementary ssRNA-selective. Similar to the case of complementary ssRNA, Tm 
was further increased by increasing the number of 2′,4′-BNANC-modification (F12-31, F12-32, 
F12-6). ∆Tm/modification for complementary ssDNA (R12D) ranging from 1.0 to 3.8 °C was 
smaller than that for complementary ssRNA (R12R) ranging from 5.3 to 6.3 °C. 
Oligonucleotide 
R12R: 3’-
r(CGCAAAAAACGA)-5’ 
R12D: 3’-
d(CGCAAAAAACGA)-5’ 
F12: 5’-d(GCGTTTTTTGCT)-3’ 45 50 
F12-1: 5’-d(GCGTTTTTTGCT)-3’a 51(+6.0) 51(+1.0) 
F12-31: 5’-d(GCGTTTTTTGCT)-3’a 64(+6.3) 55(+1.7) 
F12-32: 5’-d(GCGTTTTTTGCT)-3’a 61(+5.3) 57(+2.3) 
F12-6: 5’-d(GCGTTTTTTGCT)-3’a 83(+6.3) 73(+3.8) 
a2’,4’-BNANC-modified positions are underlined. 
Table 1. Melting temperatures of 4 µM duplexes formed between 12-base unmodified (F12) or 2’,4’-
BNANC-modified (F12-1, F12-31, F12-32, F12-6) oligonucleotides and each of complementary single-
stranded RNA (R12R) and single-stranded DNA (R12D) in 10 mM sodium phosphate buffer (pH 7.2) 
and 100 mM NaCl. The increase in melting temperature per 2’,4’-BNANC-modification 
(∆Tm/modification) is shown in parentheses. 
Because 2′,4′-BNANC-modified oligonucleotides (F12-1, F12-31, F12-32, F12-6) exhibited high 
binding affinity with complementary ssRNA (R12R) as described above, their ability to 
discriminate bases was evaluated using single-mismatched ssRNA strand (R12X; Figure 1b) 
(Table 2). Any mismatched base in the ssRNA strands (R12U, R12G, R12C) resulted in a 
substantial decrease in the Tm value of the duplexes formed with the 2′,4′-BNANC-modified 
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oligonucleotide (F12-1). The Tm values of the duplexes formed with the 2′,4′-BNANC-
modified oligonucleotide (F12-1:R12U, F12-1:R12G, F12-1:R12C) having a T-U, T-G, and T-C 
mismatched base pair were lower than those of the corresponding perfectly matched duplex 
(F12-1:R12A) by -14, -5, -17 °C, respectively. The mismatched base pair discrimination 
profile of the 2′,4′-BNANC-modified oligonucleotide (F12-1) was similar to that of the 
unmodified oligonucleotide (F12). These results indicate that 2′,4′-BNANC-modified 
oligonucleotide not only exhibits high-affinity RNA selective binding, but is also highly 
selective in recognizing bases. 
Oligonucleotide 
R12X: 3’-r(CGCAAXAAACGA)-5’ 
X = A 
(matched) 
X = U X = G X = C 
F12: 5’-d(GCGTTTTTTGCT)-3’ 45 33 42 30 
F12-1: 5’-d(GCGTTTTTTGCT)-3’a 51 37 46 34 
a2’,4’-BNANC-modified position is underlined. 
Table 2. Melting temperatures of 4 µM duplexes formed between 12-base unmodified (F12) or 2’,4’-
BNANC-modified (F12-1) oligonucleotides and complementary single-stranded RNA containing a 
single-mismatched base (R12X) in 10 mM sodium phosphate buffer (pH 7.2) and 100 mM NaCl. 
4. Stabilization of pyrimidine motif triplex at neutral pH by 2’,4’-BNANC-
modification 
Formation of stable triplex with TFO under physiological condition is essential for antigene 
application. Thermal stability of the pyrimidine motif triplexes formed between a 23-bp 
target duplex (Pur23APyr23T; Figure 1c) and each of its specific 15-mer 2’,4’-BNANC-
unmodified (Pyr15TM; Figure 1c) or 2’,4’-BNANC-modified (Pyr15NC7-1, Pyr15NC7-2, 
Pyr15NC5-1, or Pyr15NC5-2; Figure 1c) TFO was investigated at pH 6.8 by UV melting 
(Figure 2 and Table 3). UV melting curves in the both directions (heating and cooling) are 
almost superimposable in all cases, indicating that the dissociation and association processes 
are reversible. The triplex involving Pyr15TM showed two-step melting. Upon heating the 
first transition at lower temperature, Tm1 (39.1 oC), was the melting of the triplex to a duplex 
and a TFO, and the second transition at higher temperature, Tm2 (72.4 oC), was the melting of 
the duplex (Figure 2). On the other hand, the triplex involving each of the 2’,4’-BNANC-
modified TFOs showed only one transition at higher temperature, Tm. As the magnitude in 
UV absorbance change at Tm for each of the 2’,4’-BNANC-modified TFOs was almost equal to 
the sum of those at Tm1 and Tm2 for Pyr15TM (Figure 2), the transition was identified as a 
direct melting of the triplex to its constituting single-strand DNAs upon heating. The 2’,4’-
BNANC modification, therefore, increased the melting temperature of the triplex by more 
than 35 oC (Table 3), indicating that the 2’,4’-BNANC modification of TFO increased the 
thermal stability of the pyrimidine motif triplex at neutral pH. 
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TFO Tm1 (oC) Tm2 (oC) 
Pyr15TM 39.1 ± 0.1 72.4 ± 0.4 
Pyr15BNANC7-1 79.4 ± 0.6 
Pyr15BNANC7-2 85.8 ± 0.1 
Pyr15BNANC5-1 75.6 ± 0.7 
Pyr15BNANC5-2 75.6 ± 0.7 
Table 3. Melting temperatures of the triplexes between a 23-base pair target duplex (Pur23APyr23T) 
and a 15-mer TFO (Pyr15TM, Pyr15BNANC7-1, Pyr15BNANC7-2, Pyr15BNANC5-1, or Pyr15BNANC5-
2) in 10 mM sodium cacodylate-cacodylic acid (pH 6.8), 200 mM NaCl and 20 mM MgCl2. 
 
 
Figure 2. . UV melting profiles of the pyrimidine motif triplex with the specific TFO (Pyr15TM, 
Pyr15NC7-1, Pyr15NC7-2, Pyr15NC5-1, or Pyr15NC5-2) upon heating. The triplexes with Pyr15TM, 
Pyr15NC7-1, Pyr15NC7-2, Pyr15NC5-1, or Pyr15NC5-2 in 10 mM sodium cacodylate-cacodylic acid (pH 
6.8), 200 mM NaCl and 20 mM MgCl
2
 were melted at a scan rate of 0.5 °C/min with detection at 260 nm. 
The cell path length was 1 cm. The triplex nucleic acid concentration used was 1 µM. 
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5. No significant structural change of pyrimidine motif triplex at neutral 
pH by 2’,4’-BNANC-modification 
Circular dichroism (CD) spectra of the pyrimidine motif triplexes between the target duplex 
(Pur23APyr23T) and each of the 2’,4’-BNANC-unmodified (Pyr15TM) or 2’,4’-BNANC-
modified (Pyr15NC7-1, Pyr15NC7-2, Pyr15NC5-1, or Pyr15NC5-2) TFO were measured at 
20 oC and pH 6.8 (Figure 3). A significant negative band in the short-wavelength (210-220 
nm) region was observed for all the profiles (Figure 3), confirming the triplex formation 
involving each TFO[31]. The overall shape of the CD spectra was quite similar among all the 
profiles (Figure 3), suggesting that no significant change may be induced in the higher order 
structure of the pyrimidine motif triplex by the 2’,4’-BNANC modification. 
 
Figure 3. CD spectra of the pyrimidine motif triplex with the specific TFO (Pyr15TM, Pyr15NC7-1, 
Pyr15NC7-2, Pyr15NC5-1, or Pyr15NC5-2). The triplexes with Pyr15TM, Pyr15NC7-1, Pyr15NC7-2, 
Pyr15NC5-1, or Pyr15NC5-2 in 10 mM sodium cacodylate-cacodylic acid (pH 6.8), 200 mM NaCl and 20 
mM MgCl
2
 were measured at 20 
o
C in the wavelength range of 205-320 nm. The cell path length was 1 
cm. The triplex nucleic acid concentration used was 1 µM. 
6. Promotion of pyrimidine motif triplex formation at neutral pH by 2’,4’-
BNANC-modification 
The pyrimidine motif triplex formation between the target duplex (Pur23APyr23T) and 
each of the 2’,4’-BNANC-unmodified (Pyr15TM) or 2’,4’-BNANC-modified (Pyr15NC7-1, 
Pyr15NC7-2, Pyr15NC5-1, or Pyr15NC5-2) TFO was examined at pH 7.0 by EMSA (Figure 
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4). Total oligonucleotide concentration ([specific TFO (Pyr15TM or 2’,4’-BNANC-modified 
TFO)] + [nonspecific oligonucleotide (Pyr15NS2M)]) was kept constant at 1000 nM to 
minimize loss of DNA during processing and to assess sequence specificity. While 
incubation with 1000 nM Pyr15NS2M alone did not cause a shift in electrophoretic 
migration of the target duplex (see lane 1 for Pyr15TM), those with Pyr15TM or each of the 
2’,4’-BNANC-modified TFOs at particular concentrations caused retardation of the duplex 
migration owing to triplex formation[32]. The dissociation constant, Kd, of triplex formation 
was determined from the concentration of the TFO, which caused half of the target duplex 
to shift to the triplex[32]. The Kd of the triplex with Pyr15TM was estimated to be between 
250 and 1000 nM. In contrast, the Kd of the triplex with each of the 2’,4’-BNANC-modified 
TFOs was ~16 nM, indicating that the 2’,4’-BNANC modification of TFO increased the 
binding constant, Ka (= 1/Kd), of the pyrimidine motif triplex formation at neutral pH by 
more than 10-fold. The increase in the Ka by the 2’,4’-BNANC modification of TFO was 
similar in magnitude among the four modified TFOs. 
7. Thermodynamic analyses of pyrimidine motif triplex formation 
involving 2’,4’-BNANC-modified TFO at neutral pH 
We examined the thermodynamic parameters of the pyrimidine motif triplex formation 
between the target duplex (Pur23APyr23T) and each of the 2’,4’-BNANC-unmodified 
(Pyr15TM) or 2’,4’-BNANC-modified TFO at 25 °C and pH 6.8 by ITC. To investigate the pH 
dependence of the pyrimidine motif triplex formation, the thermodynamic parameters of 
the triplex formation between Pur23APyr23T and Pyr15TM were also analyzed at 25 °C 
and pH 6.1 by ITC. Figure 5a shows a typical ITC profile for the triplex formation between 
Pyr15NC7-1 and Pur23APyr23T at 25 °C and pH 6.8. An exothermic heat pulse was 
observed after each injection of Pur23APyr23T into Pyr15NC7-1. The magnitude of each 
peak decreased gradually with each new injection, and a small peak was still observed at a 
molar ratio of [Pur23APyr23T]/[Pyr15NC7-1]=2. The area of the small peak was equal to 
the heat of dilution measured in a separate experiment by injecting Pur23APyr23T into the 
same buffer. The area under each peak was integrated, and the heat of dilution of 
Pur23APyr23T was subtracted from the integrated values. The corrected heat was divided 
by the moles of injected solution, and the resulting values were plotted as a function of a 
molar ratio of [Pur23APyr23T]/[Pyr15NC7-1], as shown in Figure 5b. The resultant titration 
plot was fitted to a sigmoidal curve by a nonlinear least-squares method. The binding 
constant, Ka, and the enthalpy change, ∆H, were obtained from the fitted curve[28]. The 
Gibbs free energy change, ∆G, and the entropy change, ∆S, were calculated from the 
equation, ∆G = -RTlnKa = ∆H - T∆S, where R is gas constant and T is temperature[28]. The 
titration plots for Pyr15TM at pH 6.8 and pH 6.1 are also shown in Figure 5b. The 
thermodynamic parameters for Pyr15TM at pH 6.8 and pH 6.1 were obtained from the 
titration plots in the same way. The ITC profiles and the titration plots for each of other 2’,4’-
BNANC-modified TFOs at pH 6.8 were almost the same as those observed for Pyr15NC7-1 at 
pH 6.8. The thermodynamic parameters for each of other 2’,4’-BNANC-modified TFOs at pH 
6.8 were obtained from the titration plots in the same way. 
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Figure 4. EMSA of the pyrimidine motif triplex formation with the specific TFO (Pyr15TM, Pyr15NC7-
1, Pyr15NC7-2, Pyr15NC5-1, or Pyr15NC5-2) at neutral pH. Triplex formation was initiated by adding 
32
P-labeled Pur23APyr23T duplex (~1 nM) with the indicated final concentrations of the specific TFO 
(Pyr15TM, Pyr15NC7-1, Pyr15NC7-2, Pyr15NC5-1, or Pyr15NC5-2). The nonspecific oligonucleotide 
(Pyr15NS2M) was added to adjust the equimolar concentrations (1000 nM) of TFO 
(Pyr15TM+Pyr15NS2M, Pyr15NC7-1+Pyr15NS2M, Pyr15NC7-2+Pyr15NS2M, Pyr15NC5-1+Pyr15NS2M, 
or Pyr15NC5-2+Pyr15NS2M) in each lane. Reaction mixtures involving Pyr15TM, Pyr15NC7-1, 
Pyr15NC7-2, Pyr15NC5-1, or Pyr15NC5-2 in 50 mM Tris-acetate (pH 7.0), 100 mM NaCl, and 10 mM 
MgCl
2
 were incubated for 6 h at 37 
o
C, and then electrophoretically separated at 4 
o
C on a 15 % native 
polyacrylamide gel prepared in buffer [50 mM Tris-acetate (pH 7.0) and 10 mM MgCl
2
]. Positions of the 
duplex (D) and triplex (T) are indicated. 
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Table 4 summarizes the thermodynamic parameters for the pyrimidine motif triplex 
formation with each of Pyr15TM and the 2’,4’-BNANC-modified TFOs at 25 ˚C and pH 6.8, 
and those with Pyr15TM at 25 ˚C and pH 6.1, obtained from ITC. The signs of both ∆H 
and ∆S were negative under each condition. Because an observed negative ∆S was 
unfavorable for the triplex formation, the triplex formation was driven by a large negative 
∆H under each condition. The Ka for Pyr15TM at pH 6.1 was ~10-fold larger than that 
observed for Pyr15TM at pH 6.8, confirming, like others[5-7], that neutral pH is 
unfavorable for the pyrimidine motif triplex formation involving C+G:C triads. In 
addition, the Ka for each of the 2’,4’-BNANC-modified TFOs at pH 6.8 was ~10-fold larger 
than that observed for Pyr15TM at pH 6.8 (Table 4), indicating that the 2’,4’-BNANC 
modification of TFO increased the Ka for the pyrimidine motif triplex formation at neutral 
pH, which is consistent with the results of EMSA (Figure 4). The increase in the Ka by the 
2’,4’-BNANC modification of TFO was similar in magnitude among the four 2’,4’-BNANC-
modified TFOs. Also, although the Ka and ∆G for the triplex formation with each of the 
2’,4’-BNANC-modified TFOs at pH 6.8 and those with Pyr15TM at pH 6.1 were quite 
similar, the constituents of ∆G, that is, ∆H and ∆S, were obviously different from each 
other (Table 4). The magnitudes of the negative ∆H and ∆S for each of the 2’,4’-BNANC-
modified TFOs at pH 6.8 were significantly smaller than those observed for Pyr15TM at 
pH 6.1 (Table 4). 
TFO pH Ka (M-1) 
Ka 
(relative)
∆G  
(kcal mol-1) 
∆H  
(kcal mol-1) 
∆S  
(cal mol-1 K-1) 
Pyr15TM 6.1a (5.81 ± 0.99) x 106 13.9 -9.23 ± 0.11 -92.0 ± 1.5 -278 ± 5 
Pyr15TM 6.8b (4.19 ± 2.0) x 105 1.0 -7.67 ± 0.38 -38.5 ± 7.5 -103 ± 26 
Pyr15BNAN
C7-1 
6.8 b (5.30 ± 0.45) x 106 12.6 -9.17 ± 0.05 -56.1 ± 1.0 -157 ± 4 
Pyr15BNAN
C7-2 
6.8 b (4.10 ± 0.69) x 106 9.8 -9.02 ± 0.11 -62.1 ± 2.4 -178 ± 8 
Pyr15BNAN
C5-1 
6.8 b (3.73 ± 0.43) x 106 8.9 -8.96 ± 0.07 -54.3 ± 1.5 -152 ± 5 
Pyr15BNAN
C5-2 
6.8 b (3.82 ± 0.29) x 106 9.1 -8.98 ± 0.05 -53.8 ± 1.1 -150 ± 4 
a10 mM sodium cacodylate-cacodylic acid (pH 6.1), 200 mM NaCl and 20 mM MgCl2. b10 mM sodium cacodylate-
cacodylic acid (pH 6.8), 200 mM NaCl and 20 mM MgCl2. 
Table 4. Thermodynamic parameters for the triplex formation between a 23-base pair target duplex 
(Pur23APyr23T) and a 15-mer TFO (Pyr15TM, Pyr15BNANC7-1, Pyr15BNANC7-2, Pyr15BNANC5-1, 
or Pyr15BNANC5-2) at 25 °C, obtained from ITC 
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Figure 5. Thermodynamic analyses of the pyrimidine motif triplex formation with Pyr15TM or 
Pyr15NC7-1 at pH 6.8 and with Pyr15TM at pH 6.1 by ITC. (a) Typical ITC profiles for the triplex 
formation between Pyr15NC7-1 and Pur23APyr23T at 25 
o
C and pH 6.8. 114.7 µM Pur23APyr23T 
solution in 10 mM sodium cacodylate-cacodylic acid (pH 6.8), 200 mM NaCl and 20 mM MgCl
2
 was 
injected 20 times in 5-µl increments into 3.58 µM Pyr15NC7-1 solution, which was dialyzed against the 
same buffer. Injections were occurred over 12 s at 10-min intervals. (b) The titration plots against the 
molar ratio of [Pur23APyr23T]/ [TFO]. The data were fitted by a nonlinear least-squares method. 
(a)
(b) 
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8. Kinetic analyses of pyrimidine motif triplex formation involving 2’,4’-
BNANC-modified TFO at neutral pH 
To examine the putative mechanism involved in the increase in Ka of the pyrimidine motif 
triplex formation by the 2’,4’-BNANC modification of TFO (Figure 4 and Table 4), we 
assessed the kinetic parameters for the association and dissociation of TFO (Pyr15TM and 
the 2’,4’-BNANC-modified TFOs) with Pur23APyr23T at 25 oC and pH 6.8 by BIACORE. 
Figure 6a shows the sensorgrams representing the triplex formation and dissociation 
involving the various concentrations of Pyr15NC7-1. The injection of Pyr15NC7-1 over the 
immobilized Bt(biotinylated)-Pyr23TPur23A caused an increase in response. As shown in 
Figure 6a, an increase in the concentration of Pyr15NC7-1 led to a gradual change in the 
response of the association curves. The on-rate constant (kon) was obtained from the analysis of 
each association curve. Figure 6b shows a plot of kon against the Pyr15NC7-1 concentrations. 
The resultant plot was fitted to a straight line by a linear least-squares method. The association 
rate constant (kassoc) was determined from the slope of the fitted line[29,30]. The off-rate 
constant (koff) was obtained from the analysis of each dissociation curve (Figure 6a). As koff is 
usually independent of the concentration of the injected solution, the dissociation rate constant 
(kdissoc) was determined by averaging koff for several concentrations[29,30]. Ka was calculated 
from the equation, Ka = kassoc/kdissoc. The kinetic parameters for each of Pyr15TM and other 2’,4’-
BNANC-modified TFOs were obtained in the same way. 
TFO kassoc (M-1 s-1) 
kassoc
(relative)
kdissoc (s-1) 
kdissoc
(relative)
Ka (M-1) 
Ka 
(relative) 
Pyr15TM (2.01 ± 0.11) x 102 1.0 (1.05 ± 0.29) x 10-3 1.0 (1.91 ± 0.88) x 105 1.0 
Pyr15BN
ANC7-1 
(3.81 ± 0.60) x 102 1.9 (6.96 ± 1.14) x 10-5 0.066 (5.47 ± 2.10) x 106 28.6 
Pyr15BN
ANC7-2 
(4.61 ± 0.29) x 102 2.3 (7.99 ± 0.83) x 10-5 0.076 (5.77 ± 1.07) x 106 30.2 
Pyr15BN
ANC5-1 
(4.60 ± 0.18) x 102 2.3 (9.36 ± 1.29) x 10-5 0.089 (4.91 ± 1.01) x 106 25.7 
Pyr15BN
ANC5-2 
(4.30 ± 0.67) x 102 2.1 (6.61 ± 0.81) x 10-5 0.063 (6.51 ± 2.06) x 106 34.1 
Table 5. Kinetic parameters for the triplex formation between a 23-base pair target duplex 
(Pur23APyr23T) and a 15-mer TFO (Pyr15TM, Pyr15BNANC7-1, Pyr15BNANC7-2, Pyr15BNANC5-1, 
or Pyr15BNANC5-2) at 25 °C and pH 6.8 in 10 mM sodium cacodylate-cacodylic acid, 200 mM NaCl 
and 20 mM MgCl2, obtained from BIACORE interaction analysis system 
Table 5 summarizes the kinetic parameters for the pyrimidine motif triplex formation with 
each of Pyr15TM and the 2’,4’-BNANC-modified TFOs at 25 °C and pH 6.8, obtained from 
BIACORE. The magnitudes of Ka calculated from the ratio of kassoc to kdissoc (Table 5) were 
consistent with those obtained from ITC (Table 4). The Ka for each of the 2’,4’-BNANC-
modified TFOs at pH 6.8 was ~30-fold larger than that observed for Pyr15TM at pH 6.8, 
indicating that the 2’,4’-BNANC modification of TFO increased the Ka of the pyrimidine motif 
triplex formation at neutral pH, which supported the results of EMSA (Figure 4) and ITC 
(Table 4). The 2’,4’-BNANC modification of TFO decreased kdissoc by ~15-fold, while it 
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moderately increased kassoc by ~2-fold. Thus, the much larger Ka by the 2’,4’-BNANC 
modification of TFO resulted mainly from the decrease in kdissoc rather than the increase in kassoc. 
 
Figure 6. Kinetic analyses of the pyrimidine motif triplex formation with Pyr15NC7-1 in 10 mM sodium 
cacodylate-cacodylic acid (pH 6.8), 200 mM NaCl and 20 mM MgCl2 by BIACORE interaction analysis 
system. (a) A series of sensorgrams for the triplex formation and the dissociation of the formed triplex 
between Pyr15NC7-1 and Pur23APyr23T at 25 oC and pH 6.8. The Pyr15NC7- 1 solutions, diluted in the 
buffer to achieve the indicated final concentrations, were injected into the Bt-Pyr23TPur23A-
immobilized cuvette. The binding of Pyr15NC7-1 to Bt-Pyr23TPur23A and the dissociation of 
Pyr15NC7-1 from Bt-Pyr23TPur23A were monitored as the response against time. (b) Measured on-rate 
constants, k
on
, of the triplex formation in (a) were plotted against the respective concentrations of 
Pyr15NC7-1. The plot was fitted to a straight line (r2 = 0.97) by a linear least-squares method. 
(a)
(b)
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9. Increased stability of 2’,4’-BNANC-modified oligonucleotides in human 
serum against nuclease degradation 
A major difficulty associated with the use of oligonucleotides as in vivo agents is the 
rapid degradation of oligonucleotides by nuclease in vivo[8]. To propose the possibility 
for the application of 2’,4’-BNANC-modified oligonucleotides to the various strategies in 
vivo, we examined the resistance of the 2’,4’-BNANC-unmodified (Pyr15TM) or 2’,4’-
BNANC-modified oligonucleotides against nuclease degradation in human serum. The 
series of oligonucleotides 5′-end labeled with 32P were incubated at 37 oC in human 
serum, and their degradation was assessed by 15 % native polyacrylamide gel 
electrophoresis (Figure 7). All of Pyr15TM was degraded and converted to shorter 
oligonucleotides within 20 min of incubation. In contrast, no significant degradation of 
Pyr15NC7-2 and Pyr15NC5-2 was observed even after 120 min of incubation. These 
results indicate that the 2’,4’-BNANC modification contributed to increase the stability of 
TFOs in human serum. Because Pyr15NC7-1 and Pyr15NC5-1 containing the 2’,4’-BNANC 
modification at the 5’-end were unable to be labeled with 32P by T4 polynucleotide 
kinase, the stability of Pyr15NC7-1 and Pyr15NC5-1 in human serum was impossible to 
be examined. Thus, to investigate the resistance of all TFOs including Pyr15NC7-1 and 
Pyr15NC5-1 against nuclease degradation, their degradation was estimated by anion-
exchange HPLC after incubating the TFOs at 37 oC in human serum. Figure 8 shows the 
percentage of the intact oligonucleotides as a function of the incubation time. Only 20 % 
of intact Pyr15TM was detected after 20 min of incubation with human serum, and 
Pyr15TM was completely degraded within 60 min. On the other hand, more than 50 % of 
the 2’,4’-BNANC-modified TFOs remained intact even after 120 min of incubation with 
human serum. These results indicate that the 2’,4’-BNANC modification significantly 
increased the nuclease resistance of TFOs in human serum. The results of anion-
exchange HPLC are consistent with those of native polyacrylamide gel electrophoresis 
(Figure 7). 
10. Excellent antisense effect of 2’,4’-BNANC-modified antisense 
oligonucleotides on the expression level of PCSK9 mRNA 
We examined in vitro antisense effect of 2’,4’-BNANC-modified antisense oligonucleotides 
(Figure 1d) on the expression level of PCSK9 mRNA. A series of the concentrations of 2’,4’-
BNANC-modified antisense oligonucleotides were transfected into mouse hepatocyte cell 
line, NMuLi, by lipofectamine 2000. Total RNA was extracted from the cells at 24 hr after the 
transfection. The expression level of PCSK9 mRNA was quantitated by real-time RT-PCR 
relative to that of control housekeeping GAPDH mRNA. In all cases of the 2’,4’-BNANC-
modified antisense oligonucleotides, the expression level of PCSK9 mRNA was decreased 
upon increasing the concentration of the 2’,4’-BNANC-modified antisense oligonucleotides 
(Figure 9). The 2’,4’-BNANC-modified antisense oligonucleotides showed the excellent 
antisense effect to reduce the expression level of PCSK9 mRNA. 
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Figure 7. Stability of the specific TFOs (Pyr15TM, Pyr15BNANC7-2, and Pyr15BNANC5-2) in human 
serum. 2 pmol 32P-labeled TFOs were incubated in human serum at 37˚C, and aliquots were removed at 
the time points indicated and analyzed by 15 % native polyacrylamide gel electrophoresis. 
 
Figure 8. Stability of the specific TFOs (Pyr15TM, Pyr15NC7-1, Pyr15NC7-2, Pyr15NC5-1, and 
Pyr15NC5-2) in human serum. 1 nmol TFOs were incubated in human serum at 37 ˚C, and aliquots 
were removed at the time points indicated and analyzed by anion-exchange HPLC. The percentage of 
the intact oligonucleotides was determined and plotted as a function of the incubation time. 
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Figure 9. Relative expression level of PCSK9 mRNA as a function of the concentrations of 2’,4’-BNANC-
modified antisense oligonucleotide. The expression level of PCSK9 mRNA was quantitated by real-time 
RT-PCR relative to that of control housekeeping GAPDH mRNA. The expression level of PCSK9 mRNA 
with the addition of 2’,4’-BNANC-modified antisense oligonucleotide was divided by that without the 
addition of the antisense oligonucleotide to obtain relative expression level of PCSK9 mRNA. 
11. Discussion 
The Tm value of the duplex formed between the 2’,4’-BNANC-modified oligonucleotide and 
the complementary ssRNA or ssDNA was significantly higher than that of the duplex 
formed between the corresponding unmodified oligonucleotide and the same 
complementary ssRNA or ssDNA (Table 1). The ∆Tm/modification value for the 
complementary ssRNA was significantly larger than that for the corresponding 
complementary ssDNA (Table 1), indicating that the 2′,4′-BNANC-modified oligonucleotide 
selectively bound to the complementary ssRNA with high affinity. In addition, the 2′,4′-
BNANC-modified oligonucleotide recognized the base in the complementary strand with 
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high selectivity (Table 2). These results indicate that the 2′,4′-BNANC-modification of 
oligonucleotide promotes the duplex formation involving the complementary ssRNA with 
high sequence selectivity at neutral pH. 
The Ka of the pyrimidine motif triplex formation with Pyr15TM at pH 6.1 was ~10-fold 
larger than that observed with Pyr15TM at pH 6.8 (Table 4), which is consistent with the 
previously reported results that neutral pH is unfavorable for the pyrimidine motif triplex 
formation involving C+･G:C triads[5-7]. On the other hand, the Ka of the pyrimidine motif 
triplex formation with each of the 2’,4’-BNANC-modified TFOs at pH 6.8 was ~10-fold larger 
than that observed with Pyr15TM at pH 6.8 (Table 4). The increase in Ka at neutral pH by the 
2’,4’-BNANC modification of TFO was supported by the results of EMSA (Figure 4) and 
BIACORE (Table 5), although the magnitudes of Kd (=1/Ka) were different between EMSA 
(Figure 4) and each of ITC (Table 4) or BIACORE (Table 5) due to the difference in the 
experimental buffer conditions. In addition, the 2’,4’-BNANC modification of TFO increased 
the thermal stability of the pyrimidine motif triplex at neutral pH (Figure 2 and Table 3). 
These results indicate that the 2’,4’-BNANC modification of TFO promotes the pyrimidine 
motif triplex formation at neutral pH. 
Because the formed triplex structure involving Pyr15TM at pH 6.1 and that involving 
Pyr15TM at pH 6.8 are the same, the magnitude of ∆H and ∆S upon the triplex formation 
measured by ITC could be the same between the two conditions. However, the magnitudes 
of ∆H and ∆S for Pyr15TM at pH 6.8 were significantly smaller than those observed for 
Pyr15TM at pH 6.1 (Table 4). When the ∆H and ∆S are calculated from the fitting procedure 
of ITC, the heat observed by ITC is divided not by the effective concentration really 
involved in the triplex formation, but by the apparent concentration added to the triplex 
formation[28]. The calculation does not take it into consideration how many percentage of 
the added concentration is really effectively involved in the triplex formation. Thus, if the 
triplex formation is substoichiometric under a certain condition, the magnitudes of ∆H and 
∆S for the substoichiometric triplex formation estimated by ITC should be smaller than 
those observed for the more stoichiometric triplex formation under another condition. 
Therefore, the significantly smaller magnitudes of ∆H and ∆S for Pyr15TM at pH 6.8 relative 
to those for Pyr15TM at pH 6.1 (Table 4) suggest that the triplex formation with Pyr15TM at 
pH 6.8 was significantly more substoichiometric than that with Pyr15TM at pH 6.1, which 
was also supported by the significantly smaller magnitudes of Ka and ∆G for Pyr15TM at pH 
6.8 (Table 4). In the substoichiometric triplex formation, the cytosine bases in the TFO may 
be protonated to a lesser extent, resulting in weaker hydrogen bonding interactions and 
possibly also weaker base stacking interactions. In contrast, the Ka and ∆G for Pyr15TM at 
pH 6.1 and those for the 2’,4’-BNANC-modified TFOs at pH 6.8 were quite similar (Table 4), 
suggesting that the triplex formations under these conditions were similarly quite 
stoichiometric. Thus, to discuss the promotion mechanism of the triplex formation by the 
2’,4’-BNANC modification of TFO, the comparison of the ∆H and ∆S between Pyr15TM at pH 
6.8 and the 2’,4’-BNANC-modified TFOs at pH 6.8 is not valid due to the significant 
substoichiometry for Pyr15TM at pH 6.8. The comparison of the ∆H and ∆S between 
Pyr15TM at pH 6.1 and the 2’,4’-BNANC-modified TFOs at pH 6.8 with similar stoichiometry 
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will provide reasonable promotion mechanism of the triplex formation by the 2’,4’-BNANC 
modification of TFO, as discussed in the following. 
Although the Ka and ∆G for Pyr15TM at pH 6.1 and those for the 2’,4’-BNANC-modified 
TFOs at pH 6.8 were quite similar (Table 4), the constituents of ∆G, that is, ∆H and ∆S, were 
obviously different. The magnitudes of the negative ∆H and ∆S for the 2’,4’-BNANC-
modified TFOs at pH 6.8 were smaller than those observed for Pyr15TM at pH 6.1 (Table 4). 
The observed negative ∆H upon the triplex formation reflects major contributions from the 
hydrogen bonding and the base stacking involved in the triplex formation, the protonation 
of the cytosine bases upon the hydrogen bonding, and the accompanying deprotonation of 
the cacodylate buffer releasing the protons to bind with the cytosine bases[33-35]. The 
immobilization of electrostricted water molecules around polar atoms upon the triplex 
formation is also considered to be the major sources of the observed negative ∆H upon the 
triplex formation[33-35]. Because the degree of the protonation may be similar between the 
2’,4’-BNANC-modified TFOs at pH 6.8 and Pyr15TM at pH 6.1 due to the similar 
stoichiometry discussed above and the protons to bind with the cytosine bases are released 
from the same cacodylate buffer in both cases, the ∆H derived from the protonation of the 
cytosine bases and the accompanying deprotonation of the cacodylate buffer should be 
similar between the two cases. Also, the CD spectra showed that the higher-order structure 
of the triplexes with each of the 2’,4’-BNANC-modified TFOs was quite similar to that with 
the corresponding unmodified TFO (Figure 3), suggesting no significant change in the 
hydrogen bonding and/or the base stacking of the triplex by the 2’,4’-BNANC-modification. 
Thus, the difference in ∆H between the 2’,4’-BNANC-modified TFOs at pH 6.8 and Pyr15TM 
at pH 6.1 (Table 4) should mainly result from the contribution that the 2’,4’-BNANC-
modification may change the degree of the immobilization of water molecules around the 
polar atoms of the triplex. The polar nitrogen atom in the aminomethylene chain to bridge 
2’-O and 4’-C of the sugar moiety may possibly achieve such change. On the other hand, the 
observed ∆S upon the triplex formation is mainly contributed by the two factors, a negative 
conformational entropy change due to the conformational restraint of TFO involved in the 
triplex formation, and a positive dehydration entropy change from the release of structured 
water molecules surrounding the TFO and the target duplex upon the triplex formation[33-
35]. Therefore, one of the reason for the smaller magnitudes of the negative ∆S for the 2’,4’-
BNANC-modified TFOs at pH 6.8 in comparison with that for Pyr15TM at pH 6.1 (Table 4) 
may be based on the negative conformational entropy change. The 2’,4’-BNANC-modified 
TFO in the free state may be more rigid than the corresponding unmodified TFO, because 
the 2’-O and 4’-C positions of the sugar moiety of the 2’,4’-BNANC are bridged with the 
aminomethylene chain. The increased rigidity in the free state may cause the smaller loss of 
the conformational entropy upon the triplex formation with the 2’,4’-BNANC-modified TFO. 
Another reason for the smaller magnitudes of the negative ∆S for the 2’,4’-BNANC-modified 
TFOs at pH 6.8 relative to that for Pyr15TM at pH 6.1 (Table 4) may be derived from the 
positive dehydration entropy change. The nitrogen atom in the aminomethylene chain may 
result in the increased degree of hydration of the 2’,4’-BNANC-modified TFO in the free state. 
The increased degree of hydration in the free state may cause the larger gain of the 
dehydration entropy upon the triplex formation with the 2’,4’-BNANC-modified TFO. We 
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conclude that the smaller loss of the conformational entropy due to the increased rigidity in 
the free state and the larger gain of the dehydration entropy due to the increased degree of 
hydration in the free state may result in the smaller magnitudes of the negative ∆S for the 
2’,4’-BNANC-modified TFOs at pH 6.8, which provides a favorable component to the ∆G and 
leads to the increase in the Ka of the triplex formation at neutral pH. 
The increase in the Ka by the 2’,4’-BNANC modification was similar in magnitude among the 
four modified TFOs (Figure 4 and Tables 4 and 5), indicating that the number and position 
of the 2’,4’-BNANC modification did not significantly affect the magnitude of the increase in 
the Ka at neutral pH. The increased rigidity and the increased degree of hydration 
themselves of the 2’,4’-BNANC-modified TFO may be more important to achieve the increase 
in the Ka at neutral pH than the variation of the number and position of the 2’,4’-BNANC 
modification. Thus, other modification strategies to gain the increased rigidity of TFO and 
the increased degree of hydration of TFO may be also useful to increase the Ka at neutral pH. 
Kinetic data have demonstrated that the 2’,4’-BNANC modification of TFO considerably 
decreased the kdissoc of the pyrimidine motif triplex formation at neutral pH (Table 5). The 
decrease in the kdissoc is a plausible kinetic reason to explain the remarkable gain in the Ka at 
neutral pH by the 2’,4’-BNANC modification (Figure 4 and Tables 4 and 5). Both our 
group[35] and others[36] have previously proposed a model that triplexes form along 
nucleation-elongation processes: in a nucleation step only a few base contacts of the 
Hoogsteen hydrogen bonds may be formed between TFO and the target duplex, and this 
may be followed by an elongation step in which Hoogsteen base pairings progress to 
complete triplex formation. Both groups[35,36] have also suggested that the observed Ka, 
which is the ratio of kassoc to kdissoc, may mostly reflect a rapid equilibrium of the nucleation 
step, which is probably the rate-limiting process of the triplex formation. In this sense, the 
2’,4’-BNANC modification is considered to slow the collapse of the nucleation intermediate 
using the increased rigidity and the increased degree of hydration of 2’,4’-BNANC-modified 
TFO to increase the Ka of the pyrimidine motif triplex formation. 
The nuclease resistance of the 2’,4’-BNANC-modified TFO in human serum was significantly 
higher than that of the unmodified TFO (Figures 7 and 8). The 2’,4’-BNANC modification 
increased the nuclease resistance of TFOs in human serum. Previously, the nuclease 
resistance of the phosphorothioate backbone, in which a nonbridging oxygen of a 
phosphodiester group was replaced by a sulfur atom, was known to be significantly higher 
than that of the unmodified backbone[37,38]. However, the Ka of the triplex formation with 
the phosphorothioate modified TFO was significantly smaller than that with the unmodified 
TFO[39,40]. Thus, the phosphorothioate modification increased the nuclease resistance of 
TFO, but it decreased the triplex forming ability. On the other hand, as discussed above, the 
2’,4’-BNANC modification of TFO increased the triplex forming ability at neutral pH (Figure 
4 and Tables 4 and 5). Therefore, the 2’,4’- BNANC modification enhanced both the nuclease 
resistance of TFO and the triplex forming ability at neutral pH. We conclude that due to 
these excellent properties the 2’,4’-BNANC modification may be more favorable than the 
phosphorothioate modification upon the application of TFO to the various triplex 
formation-based strategies in vivo. 
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The 2’,4’-BNANC-modified antisense oligonucleotides showed the excellent antisense effect 
to reduce the expression level of PCSK9 mRNA (Figure 9). As discussed above, the 2′,4′-
BNANC-modified oligonucleotides exhibited significantly higher binding affinity with 
complementary ssRNA than unmodified oligonucleotides (Table 1). Also, the 2’,4’-BNANC 
modification significantly increased the nuclease resistance of oligonucleotides in human 
serum (Figures 7 and 8). The significantly higher binding affinity with complementary 
ssRNA and the significantly higher nuclease resistance of oligonucleotides in human serum 
may achieve the excellent antisense effect of the 2’,4’-BNANC-modified antisense 
oligonucleotides. We conclude that the 2’,4’-BNANC-modified antisense oligonucleotides 
may be useful to reduce the expression level of the target mRNA. 
12. Conclusion 
The present study has clearly indicated that the 2’,4’-BNANC modification increased the 
thermal stability of the duplex with complementary ssRNA and ssDNA at neutral pH. It has 
also clearly demonstrated that the 2’,4’-BNANC modification of TFO increased not only the 
thermal stability of the pyrimidine motif triplex but also the Ka of the pyrimidine motif 
triplex formation at neutral pH by more than 10-fold, which mainly resulted from the 
considerable decrease in the kdissoc. It has also revealed that the 2’,4’-BNANC modification of 
TFO significantly increased the nuclease resistance of TFO in human serum. Our results 
certainly support the idea that the 2’,4’-BNANC-modified oligonucleotides may have a 
potential to be applied to the various duplex and triplex formation-based strategies in vivo, 
such as regulation of gene expression by antisense and antigene technology, mapping of 
genomic DNA, and gene-targeted mutagenesis. In fact, the 2’,4’-BNANC-modified antisense 
oligonucleotides showed the excellent antisense effect to reduce the expression level of the 
target mRNA. In addition, the present study has revealed that the increased rigidity and the 
increased degree of hydration of the 2’,4’-BNANC-modified TFO in the free state may enable 
the significant increase in the Ka for the pyrimidine motif triplex formation at neutral pH. 
We conclude that the design of oligonucleotides to bridge different positions of sugar 
moiety with polar atom-containing alkyl chain for the increased rigidity and the increased 
degree of hydration is certainly a promising strategy for the promotion of the duplex and 
triplex formation under physiological condition, and may eventually lead to progress in 
various duplex and triplex formation-based strategies in vivo. 
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